Menorrhagia: Clinical Trials

202 trials for Menorrhagia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

112 completed, 33 unknown, 21 terminated, 16 recruiting. 69 Not applicable, 44 Phase 3, 26 Phase 4, 11 Phase 2, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable69Completed 38, Unknown 12, Terminated 9, Recruiting 5, Not yet recruiting 3, Withdrawn 2
Phase 344Completed 32, Terminated 5, Unknown 4, Recruiting 2, Withdrawn 1
Phase 426Completed 15, Unknown 7, Withdrawn 2, Not yet recruiting 1, Terminated 1
Phase 211Completed 6, Unknown 2, Recruiting 1, Terminated 1, Withdrawn 1
Phase 15Unknown 2, Completed 1, Terminated 1, Withdrawn 1
Early Phase 12Completed 1, Not yet recruiting 1

Follow Menorrhagia: new trials by email Literature Review of Menorrhagia trials Research Report on Menorrhagia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Ginger on Heavy Menstrual Bleeding in Women With Coagulation Disorders
Ginger, Placebo - Women With Coagulation Disorders
Early Phase 1Not yet recruitingUniversity of Valladolid742028-02-012026-05-19
Ultrasound-Guided Radiofrequency Ablation for Focal Adenomyosis
Myoblate Radiofrequency Ablation System (Mygen V-1000 generator) - Adenomyosis, Adenomyoma of Uterus
Not applicableNot yet recruitingUniversity Hospital Pilsen412026-11-012026-10-30
Heavy Menstrual Bleeding and Dysmenorrhea Among Undergraduate Females in the Faculty of Medicine of Assiut University
Dysmenorrhea, Heavy Menstrual Bleeding
Not yet recruitingAssiut University4862026-10-012026-10-01
HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMB
ALN-6400 - Von Willebrand Disease (VWD), Heavy Menstrual Bleeding (HMB)
Phase 2RecruitingAlnylam Pharmaceuticals242026-07-302026-10-26
Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy
Cyclobenzaprine - Minimally Invasive Surgical Procedures, Abnormal Uterine Bleeding, Unspecified
Phase 4Not yet recruitingChristiana Care Health Services362026-07-012026-06-24
Delivering tAN to Reduce HMB: The LUNA Study
Sparrow Link, Sparrow Link (Sham) - Heavy Menstrual Bleeding
Not applicableRecruitingSpark Biomedical, Inc.802026-03-062026-10-20
Clinical Spectrum and Management of Von Willebrand Disease Among Children in Assiut Governorate
Tranexamic Acid, Von Willebrand Factor-Containing Concentrates - Von Willebrand Disease (VWD), Inherited Bleeding Disorders in Children
Not yet recruitingAssiut University252026-03-012026-02-13
Effectiveness of an mHealth Innovation on the Impact of Menstrual Complaints in Adolescents
Menstrual Tracker and Education Application - Dysmenorrhea, Heavy Menstrual Bleeding
Not applicableNot yet recruitingAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)8742026-02-162026-03-09
Reframing Endometrial Physiology by Advanced Integrated Research
Menorrhagia Due to Benign Causes
RecruitingUniversity Hospital Southampton NHS Foundation Trust1002026-02-062026-04-30
to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia
KLH-2109+ Leurprorelin acetate Placebo, KLH-2109 Placebo + Leurprorelin acetate - Menorrhagia, Uterine Fibroids
Phase 3RecruitingJW Pharmaceutical2542026-02-032026-05-01
Evaluating the Reliability and Validity of the Arabic Version of the SAMANTA Questionnaire: A Step Toward Improved Diagnosis of Heavy Menstrual Bleeding
Heavy Menstrual Bleeding
Not yet recruitingAssiut University1202025-12-012025-12-05
Prevalence and Impact on Quality of Life, Academic Performance, and Blood Indices of Heavy Menstrual Bleeding Among Female Students in Assiut University, Egypt
Menorrhagia
Not yet recruitingAssiut University3402025-11-012025-09-23
Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
Levonorgestrel Intrauterine System, Norethindrone Acetate - Heavy Menstrual Bleeding, Bleeding Disorder
RecruitingOregon Health and Science University3002025-09-242026-11-02
Impact of Ehlers-Danlos Syndrome on Gynaecological Health
Ehlers-Danlos Syndrome (EDS)
RecruitingUniversity Hospital, Rouen1562025-07-072026-06-10
Moderate Aerobic Exercise for Managing Menstrual Cycle Symptoms
Moderate Aerobic Exercise - Premenstrual Syndrome, Menstrual Cycle
Not applicableRecruitingUniversity of Colorado, Colorado Springs352025-07-012025-07-24
Myo-Inositol and D-Chiro-Inositol for Menstrual Irregularities and Hormone Changes in Women With Polycystic Ovarian Syndrome
Myo-Inositol and D-Chiro-Inositol Combination Therapy, placebo (folic acid) - Polycystic Ovary Syndrome (PCOS), Myo-inositol
Phase 4CompletedNishtar Medical University602025-06-012026-07-14
Multicenter Observational Cohort Study on the Epidemiology of Therapeutic Strategies in Patients Affected by Adenomyosis
This is a non-interventional study. Treatment allocation will not be influenced by the study protocol. - Adenomyosis of Uterus, Uterine Diseases
RecruitingSCHETTINI SERGIO2002025-06-012026-03-17
A Clinical Study of the Aqua Therapeutics Thermal Therapy Vapor Ablation System in Premenopausal Women With Abnormal Uterine Bleeding
Aqua Therapeutics Thermal Therapy Vapor Ablation System (ATTTVAS) - Menorrhagia
Not applicableRecruitingAqua Therapeutics, Inc.432025-04-082026-10-30
Transcutaneous Auricular Neurostimulation as a Treatment for Women With Heavy Menstrual Bleeding: A Dose-finding Trial
Volta System - Heavy Menstrual Bleeding
Not applicableCompletedSpark Biomedical, Inc.402025-02-142025-09-26
HIFU Versus Myomectomy for the Treatment of Symptomatic Uterine Fibroids
High-Intensity Focused Ultrasound (HIFU), myomectomy - Uterine Fibroids (UF)
Not applicableRecruitingChinese University of Hong Kong1122025-02-062026-03-27

Showing 20 of 202. Sign in to see all of them.

Narrower conditions

Leiomyoma (59)  ·  Metrorrhagia (27)  ·  Dysmenorrhea (17)  ·  Adenomyosis (13)  ·  Uterine Hemorrhage (10)  ·  Endometriosis (8)  ·  Hemostatic Disorders (8)  ·  von Willebrand Diseases (8)  ·  Hemorrhage (7)  ·  Pelvic Pain (7)  ·  Anemia, Iron-Deficiency (5)  ·  Menstruation Disturbances (5)  ·  Myoma (5)  ·  Hemophilia A (4)

Broader conditions

Female Urogenital Diseases (202)  ·  Female Urogenital Diseases and Pregnancy Complications (202)  ·  Genital Diseases (202)  ·  Pathologic Processes (202)  ·  Pathological Conditions, Signs and Symptoms (202)  ·  Urogenital Diseases (202)  ·  Genital Diseases, Female (201)  ·  Uterine Diseases (201)  ·  Menstruation Disturbances (197)  ·  Hemorrhage (195)  ·  Uterine Hemorrhage (192)  ·  Neoplasms (62)  ·  Neoplasms by Histologic Type (61)  ·  Neoplasms, Connective and Soft Tissue (60)  ·  Neoplasms, Muscle Tissue (60)

Interventions

Tranexamic Acid (19)  ·  Levonorgestrel (13)  ·  Estradiol (9)  ·  estradiol, norethindrone drug combination (9)  ·  Norethindrone Acetate (8)  ·  asoprisnil (7)  ·  elagolix (7)  ·  Medroxyprogesterone Acetate (6)  ·  Uterine Artery Embolization (6)  ·  relugolix (5)  ·  Hysterectomy (4)  ·  Uterine Myomectomy (4)  ·  ulipristal acetate (4)  ·  vilaprisan (4)  ·  Iron (3)

Sponsors

Bayer (18)  ·  AbbVie (8)  ·  Assiut University (8)  ·  Abbott (7)  ·  Ferring Pharmaceuticals (5)  ·  Gynesonics (5)  ·  Minerva Surgical, Inc. (5)  ·  Myovant Sciences GmbH (5)  ·  Acessa Health, Inc. (3)  ·  Baylor College of Medicine (3)  ·  Birmingham Women's NHS Foundation Trust (3)  ·  Ethicon, Inc. (3)  ·  Oregon Health and Science University (3)  ·  University of Sao Paulo (3)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2)

Countries

United States (85)  ·  Canada (17)  ·  Netherlands (12)  ·  United Kingdom (12)  ·  China (10)  ·  Czechia (10)  ·  Brazil (9)  ·  Mexico (9)  ·  Poland (8)  ·  Egypt (7)  ·  France (7)  ·  Germany (7)  ·  Hungary (7)  ·  Israel (7)  ·  Italy (7)

Top investigators

David Toub, MD (3)  ·  Navid Khodaparast, PhD (2)  ·  ObsEva SA (2)  ·  Abimbola O. Famuyide, MBBS (1)  ·  Adam Magos, BSc MD FRCOG (1)  ·  Ahmed Ali Mohamed Nasr, M.D (1)  ·  Allison Wheeler (1)  ·  Almereau Prollius, MD (1)  ·  Amanda Yunker, DO (1)

Results publications

PMID 31971678, PMID 34878624, PMID 36357960, PMID 37477173, PMID 37863160, PMID 21043553, PMID 23188490, PMID 30865281, PMID 32835865, PMID 33544889, PMID 33596357, PMID 33650259, PMID 34553161, PMID 34582715, PMID 35415708, PMID 35675604, PMID 36116480, PMID 37183454, PMID 39381651, PMID 39466126, PMID 40326221, PMID 40543832, PMID 12423842, PMID 15547547, PMID 15958000, PMID 16880310, PMID 17012455, PMID 17197583, PMID 17671809, PMID 18055721, PMID 18567277, PMID 18752459, PMID 19111789, PMID 19682342, PMID 19955104, PMID 20378611, PMID 20472114, PMID 20733445, PMID 20859150, PMID 20942615, PMID 21173651, PMID 21475963, PMID 21777897, PMID 21833452, PMID 21867401, PMID 22748952, PMID 22959906, PMID 23340271, PMID 23395927, PMID 24613404

NIH funding

2016 (3), 2017 (2), 2018 (2), 2014 (1), 2023 (1), 2025 (1), R21HD091337 (1), U01HL133815 (1)